HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

On Pandemic Alert, Regulators See ‘Yellow Flags’ In Immunity Claims For Supplements

Executive Summary

Supplement immunity claims are more likely to get regulators’ attention when they also explain immunity’s importance, often moving into treatment claims, says attorney Justin Prochnow. Hash tags mentioning COVID-19 or staying healthy during the pandemic also can suggest products treat the virus.

You may also be interested in...



Like Consumer Health Ad Claims About COVID-19, Customer Testimonials Are False And Misleading

Nomolotus discontinued social media claims that its herbal supplement supports users’ immune systems during the COVID-19 pandemic and customers reviews referencing the virus after the National Advertising Division questioned the statements as misleading. 

No Enforcement Immunity For Testimonials On Immunity Or Claims With 'Alert: No COVID-19 Cure'

Elderberry syrup marketer Provezza Health targeted review of claims consumers may link to COVID-19 prevention or treatment due to testimonials not dispelled by the firm. FDA and FTC warn CBD firm to discontinue claims noting immunity-boosting is the “best defense” against COVID-19.

False COVID-19 Claims In US Consumer Health Market: Rampant With Forecast For More

In addition to 45 businesses with varying levels of communication skills the FTC targeted in its latest batch of warnings about false advertising linked coronavirus, the FDA "sent hundreds of abuse complaints to domain name registrars and internet marketplaces" also linked to bogus COVID-19 claims.

Related Content

Topics

UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel